Routine Immunisation Coverage Shows Signs of Recovery at Global-Level Post Pandemic, But Important and Declines Persist in 20% of Countries
Preprint
- 27 February 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: Routine immunisation (RI) coverage declines during the COVID-19 pandemic, from 2020 to 2022, are well-reported. With the declared end to the Public Health Emergency of International Concern in May 2023, and the end of most non-pharmaceutical interventions that were introduced to prevent or minimise COVID-19 spread, we (I) assess whether routine immunisation coverage has rebounded to pre-pandemic trends, and (II) seek to identify factors that help predict whether country performance has exceeded, maintained, or declined compared to expectations (based on time-series forecasting). Methods: We quantify global and country-level routine immunisation diphtheria-tetanus-pertussis (DTP) coverage trends post-pandemic (2023) compared to pre-pandemic trends using time-series forecasting across 190 countries. We used Discriminant Analysis of Principal Components and Random Forests to identify relevant predictors of country-level coverage performance, including 28 indicators of health system strength, health workforce, country income, pandemic containment, economic, and health policies, and demographic aspects. Results: We show that mean global DTP third-dose coverage levels remained on average 2.7% [95% confidence intervals: 1.1% - 4.3%] lower than expected in 2023. However, once accounting for temporal demographic changes, we find that this translates to the total number of immunised children almost reverting to expected levels, owing to decreasing fertility reducing global-level immunisation target populations. At a country-level, notable disruption remaining in over 30 countries (17.6% of countries below expectations, 81.6 within expected ranges, and 1.7% above expectations). Neither predictive method performed well at identifying factors associated with coverage disruptions. Conclusions: Despite the end of COVID-19 pandemic measures, RI remains below expectations in 20% of countries. No clear drivers of this continued disruption were identified. Further research is required to inform recovery efforts and prevent future epidemic and pandemic disruptions to routine health services.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling studyThe Lancet Global Health, 2024
- Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022Vaccine: X, 2023
- Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemicVaccine, 2022
- Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling studyThe Lancet, 2021
- Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine HesitancyJournal of Community Health, 2021
- Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutionsThe Lancet Regional Health - Western Pacific, 2021
- Vaccine hesitancy in the era of COVID-19Public Health, 2021
- A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)Nature Human Behaviour, 2021
- Analysis of a complex of statistical variables into principal components.Journal of Educational Psychology, 1933